Clinical Trials Logo

Loss-of-control Eating clinical trials

View clinical trials related to Loss-of-control Eating.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04605081 Enrolling by invitation - Obesity/Overweight Clinical Trials

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

Start date: January 10, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the effectiveness of naltrexone/bupropion medication as a maintenance therapy for the treatment of loss-of-control eating and weight loss following bariatric surgery. This is a controlled test of whether, amongst responders to acute treatments, naltrexone/bupropion medication results in superior maintenance and longer-term outcomes compared with placebo.

NCT ID: NCT04599504 Enrolling by invitation - Obesity/Overweight Clinical Trials

Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)

Start date: January 2, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the effectiveness of lisdexamfetamine medication as a treatment for loss-of-control eating and weight following bariatric surgery. This is a controlled test of whether, amongst non-responders to acute treatments, lisdexamfetamine medication results in superior outcomes compared with placebo.